skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Targeted disruption of murine ornithine aminotransferase gene: Surprising neonatal lethality rescued by arginine therapy and possible mouse model for gyrate atrophy

Journal Article · · American Journal of Human Genetics
OSTI ID:133277
; ;  [1]
  1. Johns Hopkins Univ. School of Medicine, Baltimore, MD (United States); and others

Deficiency of ornithine-{delta}-aminotransferase (OAT) in humans results in gyrate atrophy (GA), an autosomal recessive blinding disorder characterized by progressive chorioretinal degeneration and hyperornithinemia. GA patients are otherwise asymptomatic. The explanation for the unique susceptibility of retina to this inborn error is not known. Poor understanding of the pathophysiology hampers development of effective therapy. To address these problems, we undertook targeted disruption of the murine OAT gene. We isolated a 13 kb genomic DNA fragment containing the first five exons of OAT from an AB1 mini-genomic library and made a replacement type targeting vector with the NEOR gene inserted into OAT exon 3 at codon 40. Following electroporation and selection, 4.4% of G418 resistant ES clones had undergone homologous recombination. Chimeric animals produced by blastocyst injection transmitted the disrupted OAT allele. Mice homozygous for OAT disruption (-/-) have no detectable OAT activity in their tissues. Although normal at birth, they die within 10 to 48 hrs. We hypothesize this lethality results from a block in gut arginine biosynthesis, a pathway that requires {open_quotes}reverse{close_quotes} OAT flux and is apparently critical for rapidly growing neonatal mice. Amino acid measurements reveal extreme reduction in urea cycle intermediates in dying mice. With i.p. arginine administration for the first 14 days of life, we have successfully obtained adult (-/-) mice. Plasma amino acids on these mice show a 10-15 fold increase in ornithine and a 2 fold decrease in lysine, biochemical hallmarks of GA. ERG and retinal histopathologic studies are in progress to examine the ocular phenotypes. These mice will provide an invaluable model to test strategies to reduce ornithine accumulation and should also prove useful in understanding the pathophysiology of retina degeneration.

OSTI ID:
133277
Report Number(s):
CONF-941009-; ISSN 0002-9297; TRN: 95:005313-0004
Journal Information:
American Journal of Human Genetics, Vol. 55, Issue Suppl.3; Conference: 44. annual meeting of the American Society of Human Genetics, Montreal (Canada), 18-22 Oct 1994; Other Information: PBD: Sep 1994
Country of Publication:
United States
Language:
English

Similar Records

HMG-CoA lyase (HL) gene: Cloning and characterization of the 5{prime} end of the mouse gene, gene targeting in ES cells, and demonstration of large deletions in three HL-deficient patients
Journal Article · Thu Sep 01 00:00:00 EDT 1994 · American Journal of Human Genetics · OSTI ID:133277

Molecular basis of ornithine aminotransferase deficiency in B-6-responsive and -nonresponsive forms of gyrate atrophy
Journal Article · Wed Jun 01 00:00:00 EDT 1988 · Proceedings of the National Academy of Sciences of the United States of America; (USA) · OSTI ID:133277

Molecular cloning of human ornithine aminotransferase mRNA
Journal Article · Sat Mar 01 00:00:00 EST 1986 · Proc. Natl. Acad. Sci. U.S.A.; (United States) · OSTI ID:133277